Back to search
FDAFDA · Food and drugs·Recall number D-0706-2022

Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15

Published March 30, 2022 · Recall initiated: March 14, 2022

Summary

FDA records drug Class II recall D-0706-2022, published March 30, 2022 and initiated March 14, 2022. Recalling firm: Athenex Pharma Solutions, LLC; Status: Terminated; Reported quantity: 4,270 bags; Lot: Lot #: F2101628, F2101629, F2101630, F2101631, Exp 4/28/22; F2101632, F2101633, Exp 4/29/22; F2101795, F2101796, Exp 5/27/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Athenex Pharma Solutions, LLC
Distributor
USA nationwide.
Lot
Lot #: F2101628, F2101629, F2101630, F2101631, Exp 4/28/22; F2101632, F2101633, Exp 4/29/22; F2101795, F2101796, Exp 5/27/22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15 recalled?

Yes. FDA published recall D-0706-2022 on March 30, 2022. Reported hazard: Defective container

What should I do if I have this product?

Voluntary: Firm initiated · Letter